Document is current
Any future updates will be listed below
-
Authors
Rayner, Fiona http://orcid.org/0000-0003-4302-0899
Anderson, Amy E.
Baker, Kenneth F.
Buckley, Christopher D.
Dyke, Bernard
Fenton, Sally
Filer, Andrew
Goodyear, Carl S.
Hilkens, Catharien M. U.
Hiu, Shaun
Kerrigan, Sean
Kurowska-Stolarska, Mariola
Matthews, Fiona
McInnes, Iain
Ng, Wan-Fai
Pratt, Arthur G.
Prichard, Jonathan
Raza, Karim
Siebert, Stefan
Stocken, Deborah
Teare, M. Dawn
Young, Stephen
Isaacs, John D.
-
Funding
Funding for this research was provided by:
Medical Research Council (MR/N026977/1)
- License Information
-
More Information
Article History
Received: 10 March 2021
Accepted: 9 April 2021
First Online: 19 July 2021
Declarations
:
: The BIO-FLARE study was reviewed and approved by the North East – Newcastle and North Tyneside 1 Research Ethics Committee on 6th February 2018, REC reference 17/NE/0386. HRA approval was gained on 23rd February 2018 (IRAS ID 234030). The study is being conducted in compliance with Good Clinical Practice and the Research Governance Framework for Health and Social Care. Patients wishing to take part provide written informed consent by signing and dating a study specific consent form, obtained prior to any study-specific procedures. The study is registered in the ISRCTN registry (identifier 16371380) [CitationRef removed].
: Not applicable
: KFB, AGP, and JDI are named as inventors on a patent application filed by Newcastle University relating to the prediction of drug-free remission in rheumatoid arthritis (PCT/GB2019/050902). The remaining authors declare no competing interests.
